HealthEquity (HQY) Director Sells $425k in Company Stock
HEALTHEQUITY, INC.
Subscribe to track HQY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
HealthEquity (HQY) Director Sells $425k in Stock
Company: HEALTHEQUITY, INC. (HQY) Form: 4 | Filed: 2025-12-16 Significance: Low
Insider: Wellborn Gayle Furgurson Title: null | Relationship: Director
Transaction: • Type: Sell (following option exercise) • Shares: 4,339 • Price: $98.03 • Value: $425,335 • Owned After: 19,733
Key Insight: A director sold shares acquired via an option exercise. This is a common 'exercise-and-sell' transaction, often for liquidity or to cover taxes, and is not typically a bearish signal.
Market Context: The sale represents a negligible 0.005% of shares outstanding for the $8.77B company, indicating minimal market impact.
Comprehensive Analysis
SEC Filing Analysis: HEALTHEQUITY, INC. (HQY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director conducted a routine 'exercise-and-sell' transaction, realizing gains on stock options. The sale's value is insignificant relative to the company's market capitalization.
- Market Impact: Minimal market impact is expected due to the transaction's small size.
Company Information
| Field | Value |
|---|---|
| Company | HEALTHEQUITY, INC. |
| Ticker Symbol | HQY |
| CIK | 0001428336 |
| Industry | SERVICES-BUSINESS SERVICES, NEC |
Insider Information
| Field | Value |
|---|---|
| Name | Wellborn Gayle Furgurson |
| CIK | 0001712960 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
This filing reports an option exercise followed by an immediate sale of the acquired shares. The primary economic event is the sale.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-12 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 4,339 |
| Price Per Share | $98.0251 |
| Total Value | $425,335.06 |
| Shares Owned After | 19,733 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $425,335.06 |
| % of Market Cap | 0.0049% |
| Shares Transacted | 4,339 |
| % of Shares Outstanding | 0.0050% |
| Post-Transaction Ownership | 19,733 shares (0.023% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $425k sale is negligible for a company with an $8.77 billion market capitalization.
- Ownership Concentration: The insider's post-transaction ownership of 19,733 shares constitutes a very small fraction (0.023%) of total shares outstanding, indicating low ownership concentration from this individual.
- Transaction Significance: The sale represents approximately 18% of the director's holdings prior to the sale. While a notable portion of her personal stake, the overall size is too small relative to the company's public float and market cap to be considered significant.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is an 'exercise-and-sell' to realize gains from options, not an open-market sale of long-held shares. The size is immaterial to the company's overall valuation and liquidity, suggesting it is not based on a change in the insider's outlook.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. This type of transaction is common and does not typically influence market sentiment.
Additional Context
Transaction Notes
- Context: The insider exercised 4,339 stock options at a price of $50.41 per share and subsequently sold the same number of shares at a weighted average price of $98.03. This is a standard method for insiders to monetize vested options.
- Footnotes: Footnote 1 confirms the sale price is a weighted average, a standard disclosure for block trades.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
